You have read all your free articles, to continue reading subscribe to read the rest of this content.
The bioink company has entered an agreement with the owners of Cytena to acquire all its shares for a purchase price of 30.25M euros. Through cytena’s complementary technology offering, Cellink sees great synergies that will support future growth. About Cytena Cytena is a life science companyAlready a subscriber Login You…
The financing was led by Finland’s Lifeline Ventures, an early-stage venture capital firm founded by serial entrepreneurs. This follows on from the first close of 10 million EUR in June 2022. This final close of 12 million EUR includes 5.9 million EUR equity from the European Innovation CouncilAlready a subscriber…
BioGaia's subsidiary TwoPac is setting up another production unit in Eslöv, in the south of Sweden. TwoPac AB was founded in 2002 to develop and manufacture packaging solutions for probiotics and is since June 2013 entirely owned by BioGaia. TwoPac mainly produces drops and straws with probioticAlready a subscriber Login…
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Calquence (acalabrutinib) as a monotherapy treatment for adult patients with chronic lymphocytic leukaemia (CLL). “This is an important regulatory milestone for our work in haematology and for patieAlready a subscriber Login You have read all your…
